The Folistrong Natural Red Onion Hair Oil has been introduced by Chezgreen, a division of Cadila Pharmaceuticals.
Ahmedabad: Cadila Pharmaceuticals, one of the largest and oldest privately held drug manufacturers in the country, has introduced a revolutionary haircare and beauty product to the Indian market, reinforcing its commitment to enhancing personal well-being.
Cadila Pharmaceuticals’ breakthrough Folistrong Natural Red Onion Hair Oil helps fight hair and scalp problems. The nutrient-rich hair oil is a blend of cold-pressed oils including sweet almond oil, extra virgin olive oil, castor oil, jojoba oil, Moroccan argan oil, and coconut oil. With regular use, the oil improves blood circulation in the scalp, strengthens hair strands, enhances hair growth, and restores natural shine and softness. The oil is non-sticky and non-greasy and suitable for all hair types.
“Hair and scalp health is an integral part of overall health and well-being. Folistrong Naturals Red Onion Hair Oil is the perfect solution for dealing with frizz, hair fall and dullness and embracing healthy and shiny hair. It is one of the many products we are launching to promote overall well-being and beauty. We are confident that the hair oil and our other products will receive excellent response from users,” said Ms Vandana Modi, Vice President of Cadila Pharmaceuticals’ Herbal Division.
The Folistrong Naturals Red Onion Hair Oil has been introduced by Chezgreen, a division of Cadila Pharmaceuticals.
About Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Ltd. is one of India’s leading integrated privately held pharmaceutical firms, located in Ahmedabad, Gujarat. The firm develops and produces pharmaceutical products in India and sells and distributes them in over 100 countries. The organization places a high priority on research, whether it is in biotechnology, APIs, formulations, plant tissue culture or phytochemistry to innovate in various therapeutic areas including gastrointestinal, cardiology, pulmonary, oncology, gynaecology, cardiovascular, Diabetology, and osteology. Its commitment to create affordable miracles in therapeutic areas with significant unmet medical needs has led to several world-first breakthroughs.
